In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, April 30, 2026.
Dr. Atosa Khan celebrates three decades of dental excellence and 20 years of independent practice at one of Northeast Florida’s most distinguished dental offices. ST. AUGUSTINE, ...
DOGP believes its ownership of PrestoDoctor positions the Company at the intersection of telehealth delivery and regulated healthcare access. PrestoDoctor’s platform is designed to support scalable ...
Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses. Recommendation based on the HERCULES ...
Internet Posting of Information Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at The Company encourages investors and ...
Eversense 365 was approved by the United States Food and Drug Administration in September of 2024 and launched across the country in October of the same year. In February 2026, Senseonics announced ...
Fox Run Eye Care launches free carotenoid screenings for Seacoast families — and brings 25 years of patient-first optometry to a stunning new vision center in Greenland, NH GREENLAND, N.H., April 24, ...
A positive CHMP opinion for Itvisma is an important step toward addressing this gap." Professor Tim Hagenacker, Department of Neurology, University Hospital Essen, Essen, Germany, said: “Itvisma met ...
Today’s announcement builds on the progress Amphista has made since it disclosed its SMARCA2 and TEAD programs in September 2025 and follows the recent presentation of AMX-883, an orally bioavailable, ...
Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), will today present positive data from its Phase II study of LEVI-04 in ...
The Geneva College of Longevity Science (GCLS) today announced the launch of the world’s first PhD in Medicine with a specialization in Longevity Sciences, developed in academic partnership with ...
IBA gathers the most knowledgeable proton therapy experts coming from the most prestigious cancer care institutions. Louvain-La-Neuve, Belgium, April 24, 2026 –IBA (Ion Beam App ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results